Skip to main content

Marta Torres Ferrús

Sóc Llicenciada en Medicina per la Universitat Autònoma de Barcelona. Em vaig especialitzar en Neurologia a l'Hospital Universitari Vall d'Hebron on continuo la meva activitat assistencial i investigadora a la Unitat de Cefalees del Servei de Neurologia.

Institutions of which they are part

Main researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca
Neurology
General Hospital

Marta Torres Ferrús

Institutions of which they are part

Main researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca
Neurology
General Hospital

Sóc Llicenciada en Medicina per la Universitat Autònoma de Barcelona. Em vaig especialitzar en Neurologia a l'Hospital Universitari Vall d'Hebron on continuo la meva activitat assistencial i investigadora a la Unitat de Cefalees del Servei de Neurologia.

Sóc membre de la "International Headache Society", Grup d'Estudi de Cefalees de la Societat Espanyola de Nerurologia (GECSEN) i de la Societat Catalana de Neurologia.
He rebut múltiples beques per a la realització de projectes de investigació. He publicat articles originals i de revisió i tinc experiència en la realització d'assajos clínics.

Projects

BiOmarcadores Moleculares y clínicos de respuesta al tratamiento en los Ataques de Migraña (Estudio MAMBO).

IP: Marta Torres Ferrús
Collaborators: Alicia Alpuente Ruiz, Laila Asskour, Eulalia Gine Cipres, Victor José Gallardo Lopez, Edoardo Caronna, Laura Gómez Dabó
Funding agency: Instituto de Salud Carlos III
Funding: 75020
Reference: PI22/01530
Duration: 01/01/2023 - 31/12/2025

Cefalea i dolor neurològic

IP: Patricia Pozo Rosich
Collaborators: Alicia Alpuente Ruiz, Laila Asskour, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez, Nara Ikumi Montserrat, Marta Vila Pueyo, Edoardo Caronna
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00406
Duration: 01/01/2022 - 30/06/2025

AhEAD: Algoritmo de predicción de Eficacia de respuesta A tratamiento preventivo en pacientes con migraña crónica: marcaDores biológicos y clínicos

IP: Patricia Pozo Rosich
Collaborators: Alicia Alpuente Ruiz, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez, Edoardo Caronna
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/01684
Duration: 01/01/2020 - 30/06/2024

BIOMIGA: un abordaje multidisciplinar para la identificacion de biomarcadores en migraña: estudio prueba de concepto basado en la estratificación de respondedores a anticuerpos monoclonales contra el CGRP

IP: Patricia Pozo Rosich
Collaborators: Alicia Alpuente Ruiz, Laila Asskour, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 99999.97
Reference: AC19/00124
Duration: 01/01/2020 - 30/06/2024

Related news

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

The study, conducted in more than 770 people, concludes that atogepant reduces the frequency of migraine attacks and the need to take medication.

Related professionals

Sebastian Lazaro

Sebastian Lazaro

Research technician
Genetics Medicine
Read more
Anna Llort Sales

Anna Llort Sales

Childhood Cancer and Blood Disorders
Read more
Marc Simo Perdigo

Marc Simo Perdigo

Molecular Medical Imaging
Read more
Joaquim Sola  Santesmases

Joaquim Sola Santesmases

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.